| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Mark H. Cheung CEO | SET Exchange | US4657331033 ISIN |
| US Country | 3 Employees | - Last Dividend | 21 Mar 2007 Last Split | - IPO Date |
Itonis, Inc. is a development stage company with its focus on the production and marketing of over-the-counter and prescription homeopathic preparations aimed at treating common ailments and chronic diseases. Originally known as Kenshou, Inc., the company underwent a name change to Itonis, Inc. in December 2005 and has since been working towards bringing innovative health solutions to the market. Founded in 2005 and headquartered in Laguna Hills, California, Itonis, Inc. is dedicated to providing alternatives to traditional medication through its developed homeopathic and natural products.
Itonis, Inc. focuses on the development and marketing of over-the-counter homeopathic preparations designed to alleviate common ailments and chronic diseases. These preparations aim to offer a natural and alternative solution to traditional medications, catering to individuals seeking homeopathic remedies.
The company is in the process of introducing its Emesyl product line, targeted at providing relief from mild to moderate nausea. Emesyl signifies Itonis, Inc.'s entry into the market with a specific solution for nausea relief, demonstrating the company's commitment to expanding its range of homeopathic remedies. A manufacturing order for the first batch of Emesyl products has already been placed, indicating the company’s move towards large-scale distribution.